PREVALENCIA DE HOSPITALIZACIONES POR SÍNDROME RESPIRATORIO AGUDO GRAVE EN RIO GRANDE DO SUL EN EL PERÍODO DE 2023 A 2024
DOI:
https://doi.org/10.56238/bocav25n74-036Palabras clave:
Incidencia, Hospitalizaciones, Prevalencia, Síndrome Respiratorio Agudo Grave, NotificaciónResumen
El síndrome respiratorio agudo grave (SRAG) representa un importante problema de salud pública, ya que es responsable de altos índices de morbilidad y mortalidad en Brasil. El presente estudio tiene como objetivo delinear el perfil de las hospitalizaciones por SRAG en el estado de Rio Grande do Sul en el período de 2023 a 2024. Se trata de un estudio exploratorio epidemiológico descriptivo, analítico y retrospectivo con un enfoque cuantitativo. Los datos se recopilaron a partir del SIVEP-gripe (Sistema de Vigilancia Epidemiológica de la Gripe) en el período comprendido entre 2023 y 2025. Los datos arrojaron un número absoluto de 17 644 hospitalizaciones, con una incidencia del 29,99 %, de las cuales un 25,11 % tuvo una incidencia hospitalaria del 17,06 %. Al analizar los datos, se observa la importancia de la prevención y la intervención temprana para reducir los casos graves y mortales de la enfermedad. El presente estudio identificó que, a pesar de los avances, las hospitalizaciones por SRAG representan un índice elevado, lo que sugiere la necesidad de intensificar las campañas de prevención y lucha contra la enfermedad.
Referencias
ANTONELLI M, PENFOLD RS, MERINO J, SUDRE CH, MOLTENI E, BERRY S, CANAS LS, GRAHAM MS, KLASER K, MODAT M, MURRAY B, KERFOOT E, CHEN L, DENG J, ÖSTERDAHL MF, CHEETHAM NJ, DREW DA, NGUYEN LH, PUJOL JC, HU C, SELVACHANDRAN S, POLIDORI L, MAY A, WOLF J, CHAN AT, HAMMERS A, DUNCAN EL, SPECTOR TD, OURSELIN S, STEVES CJ.” Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study”. Lancet Infect Dis 2022; 22(1):43-55. DOI: https://doi.org/10.1016/S1473-3099(21)00460-6
ARROYO-SÁNCHEZ A, AGUIRRE-MEJÍA R. “To: Factors associated with mortality in mechanically ventilated patients with severe acute respiratory syndrome due to COVID-19” evolution. Crit Care Sci. 2024 Jun 17;36:e20240192en. doi: 10.62675/2965-2774.20240192-en. PMID: 38896722; PMCID: PMC11152438. DOI: https://doi.org/10.62675/2965-2774.20240192-en
BRASIL. Ministério da Saúde (MS). “Secretaria de Vigilância em Saúde. Plano Nacional de Operacionalização da Vacinação contra a COVID-19”. Brasília: MS; 2020.
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). COVID-19 Clinical Presentation [Internet]. 2024 [cited 2024 maio 20]. Available from: https://www.cdc.gov/covid/hcp/clinical-care/covid19-presentation.html
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). “COVID-19 People with Certain Medical Conditions and COVID-19 Risk Factors” [Internet]. 2024 [cited 2024 jul 23]. Disponível em: https://www.cdc.gov/covid/risk-factors/index.html
» https://www.cdc.gov/covid/risk-factors/index.html
E SOUZA LUNA LK, CRUZ JS, CHAVES TDSS, BELLEI N. “Comparative analysis of Respiratory Syncytial Virus frequency rates and viral load in different patient cohorts in a University Hospital in São Paulo, Brazil, over an eight-year period (2005-2013)”. Braz J Infect Dis. 2023 Nov-Dec;27(6):103702. doi: 10.1016/j.bjid.2023.103702. Epub 2023 Nov 30. PMID: 38043582; PMCID: PMC10714327. DOI: https://doi.org/10.1016/j.bjid.2023.103702
ESPINOSA-GONZALEZ A, PROCIUK D, FIORENTINO F, RAMTALE C, MI E, MI E, GLAMPSON B, NEVES AL, OKUSI C, HUSAIN L, MACARTNEY J, BROWN M, BROWNE B, WARREN C, CHOWLA R, HEAVERSEDGE J, GREENHALGH T, DE LUSIGNAN S, MAYER E, DELANEY BC. “Remote COVID-19 Assessment in Primary Care (RECAP) risk prediction tool: derivation and real-world validation studies”. Lancet Digit Health 2022; 4(9):e646-e656. DOI: https://doi.org/10.1016/S2589-7500(22)00123-6
FARIAS, G. M. . .; SANTOS, M. O. do; COSTA , M. J. S. da .; LIMA , I. S. L. e .; TRIGUEIRO, W. F. . Prevalência das Internações por COVID-19 em um hospital de referência no estado da paraíba em 2024 . Boletim de Conjuntura (BOCA), Boa Vista, v. 23, n. 68, p. 257–275, 2025. DOI: 10.5281/zenodo.17096326. Disponível em: https://revista.ioles.com.br/boca/index.php/revista/article/view/7681. Acesso em: 23 out. 2025.
FRANCO VF, ZACCARA TA, FERREIRA OS, DA COSTA RA, RODRIGUES AS, FRANCISCO RP. “Unveiling the hidden burden of COVID-19 in Brazil's obstetric population with severe acute respiratory syndrome: A machine learning model. PLoS One”. 2025 Aug 22;20(8):e0330375. doi: 10.1371/journal.pone.0330375. PMID: 40845003; PMCID: PMC12373234. DOI: https://doi.org/10.1371/journal.pone.0330375
HIPPISLEY-COX J, KHUNTI K, SHEIKH A, NGUYEN-VAN-TAM JS, COUPLAND CAC. “Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study”. BMJ 2023; 381:e072976. DOI: https://doi.org/10.1136/bmj-2022-072976
INFECTION DISEASE SOCIETY OF AMERICA (IDS) [Internet]. 2024 [cited 2024 jun 21]. Disponível em: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/.
» https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management
LIRA NETO JCG, ARAÚJO MFM, MONTEIRO FPM, FREITAS RWJF, TEIXEIRA CRS, SANTOS FS, COSTA ACPJ, SANTOS NETO M, PASCOAL LM. “Association between chronic health conditions and severe acute respiratory syndrome in pregnant women: an exploratory study”. Rev Esc Enferm USP. 2024 Nov 22;58:e20230336. doi: 10.1590/1980-220X-REEUSP-2023-0336en. PMID: 39584800; PMCID: PMC11583968. DOI: https://doi.org/10.1590/1980-220x-reeusp-2023-0336pt
MENNI C, VALDES AM, POLIDORI L, ANTONELLI M, PENAMAKURI S, NOGAL A, LOUCA P, MAY A, FIGUEIREDO JC, HU C, MOLTENI E, CANAS L, ÖSTERDAHL MF, MODAT M, SUDRE CH, FOX B, HAMMERS A, WOLF J, CAPDEVILA J, CHAN AT, DAVID SP, STEVES CJ, OURSELIN S, SPECTOR TD. “Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID” Study. Lancet 2022; 399(10335):1618-1624. DOI: https://doi.org/10.1016/S0140-6736(22)00327-0
NYBERG T, FERGUSON NM, NASH SG, WEBSTER HH, FLAXMAN S, ANDREWS N, HINSLEY W, BERNAL JL, KALL M, BHATT S, BLOMQUIST P, ZAIDI A, VOLZ E, AZIZ NA, HARMAN K, FUNK S, ABBOTT S; COVID-19 GENOMICS UK (COG-UK) CONSORTIUM; HOPE R, CHARLETT A, CHAND M, GHANI AC, SEAMAN SR, DABRERA G, DE ANGELIS D, PRESANIS AM, THELWALL S. “Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study”. Lancet 2022; 399(10332):1303-1312. DOI: https://doi.org/10.1016/S0140-6736(22)00462-7
ORGANIZAÇÃO PAN-AMERICANA DA SAUDE. COVID-19 e as Pessoas Idosas. Paho.org, 2020. Disponível em: https://www.paho.org/pt/ envelhecimento-saudavel/covid-19-e-pessoas-idosas
WANG S, ZHU R, ZHANG C, GUO Y, LV M, ZHANG C, BIAN C, JIANG R, ZHOU W, GUO L. “Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis”. PLoS One 2023; 18(10):e0292021. DOI: https://doi.org/10.1371/journal.pone.0292021
WYNANTS L, CALSTER B, COLLINS GS, RILEY RD, HEINZE G, SCHUIT E, BONTEN MMJ, DAHLY DL, DAMEN JAA, DEBRAY TPA, JONG VMT, DE VOS M, DHIMAN P, HALLER MC, HARHAY MO, HENCKAERTS L, HEUS P, KAMMER M, KREUZBERGER N, LOHMANN A, LUIJKEN K, MA J, MARTIN GP, MCLERNON DJ, ANDAUR NAVARRO CL, REITSMA JB, SERGEANT JC, SHI C, SKOETZ N, SMITS LJM, SNELL KIE, SPERRIN M, SPIJKER R, STEYERBERG EW, TAKADA T, TZOULAKI I, KUIJK SMJ, VAN BUSSEL B, HORST ICC, ROYEN FS, VERBAKEL JY, WALLISCH C, WILKINSON J, WOLFF R, HOOFT L, MOONS KGM, SMEDEN M. “Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal (versão 4)”. BMJ 2022; 369:m1328. DOI: https://doi.org/10.1136/bmj.m1328
SOUSA A. M. “Planilha Interna de Controle de Casos e Óbitos do Núcleo Hospitalar de Epidemiologia do Hospital Estadual de Jataí”. Disponível no sistema interno de informática do Hospital Estadual de Jataí, Goiás, 2023.
Descargas
Publicado
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Copyright (c). Boletim de Coyuntura (BOCA)
Este obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional.
